Document is current
Any future updates will be listed below
-
Authors
Saxena, Manish https://orcid.org/0000-0001-9964-2692
Schmieder, Roland E. https://orcid.org/0000-0003-2356-5883
Kirtane, Ajay J.
Mahfoud, Felix https://orcid.org/0000-0002-4425-549X
Daemen, Joost
Basile, Jan
Lurz, Philipp
Gosse, Philippe https://orcid.org/0000-0002-5840-7749
Sanghvi, Kintur
Fisher, Naomi D. L.
Rump, Lars C.
Pathak, Atul
Blankestijn, Peter J.
Mathur, Anthony
Wang, Yale https://orcid.org/0000-0002-8780-5113
Weber, Michael A. https://orcid.org/0000-0002-8504-0831
Sharp, Andrew S. P.
Bloch, Michael J.
Barman, Neil C. https://orcid.org/0000-0001-5713-6716
Claude, Lisa
Song, Yang
Azizi, Michel
Lobo, Melvin D. https://orcid.org/0000-0002-1122-948X
-
Funding
Funding for this research was provided by:
ReCor Medical Palo Alto, CA, USA
ReCor Medical, Palo Alto, CA, USA
- License Information
-
More Information
Article History
Received: 5 January 2021
Revised: 9 April 2021
Accepted: 23 April 2021
First Online: 24 May 2021
Compliance with ethical standards
:
: MS has received grant support and personal fees from ReCor Medical. RES has received grant support and personal fees from ReCor Medical, Medtronic, and Ablative Solutions. AJK reports Institutional funding to Columbia University and/or Cardiovascular Research Foundation from Medtronic, Boston Scientific, Abbott Vascular, Abiomed, CSI, CathWorks, Siemens, Philips, ReCor Medical. In addition to research grants, institutional funding includes fees paid to Columbia University and/or Cardiovascular Research Foundation for speaking engagements and/or consulting. Personal: Consulting: Neurotronic; Travel Expenses/Meals from Medtronic, Boston Scientific, Abbott Vascular, Abiomed, CSI, CathWorks, Siemens, Philips, ReCor Medical, Chiesi, OpSens, Zoll, and Regeneron. FM is supported by Deutsche Gesellschaft für Kardiologie (DGK), and Deutsche Forschungsgemeinschaft (SFB TRR219) and has received scientific support and speaker honoraria from Bayer, Boehringer Ingelheim, Medtronic and ReCor Medical. JD has received grant support from ReCor Medical, Medtronic, Boston Scientific, Abbott Vascular, Acist Medical, Astra Zeneca, Pie Medical, and Pulse Cath and has received personal fees from ReCor Medical, Medtronic, Acist Medical, Boston Scientific, Pie Medical, and Pulse Cath. JB has received grant support from ReCor Medical and Ablative Solutions. PL has received grant support and personal fees from ReCor Medical, Edwards, and Abbott and personal fees from Medtronic and Occlutech. PG has received grant support from Recor and Ablative Solutions. KS has received grant support and personal fees from ReCor Medical and Medtronic and grant support from CSI. NDLF has received grant support and personal fees from ReCor Medical. LCR has received personal fees and other support from ReCor Medical. AP has received personal fees from ReCor Medical, Medtronic, CVRx, Ablative Solutions, Dynamics, ROX Medical and grants from Medtronic, Ablative Solutions, ReCor Medical and CVRx. PJB reports institutional funding by the European Commission, Recor, Medtronic, Ablative Solutions, Fresenius and BBraun. MAW has received personal fees from ReCor Medical, Medtronic, Boston Scientific, and Ablative Solutions. ASPS has received personal fees from ReCor Medical, Medtronic and Philips. MJB has received personal fees from ReCor Medical and Medtronic. NCB is an employee of ReCor Medical and has multiple patents in renal denervation issued. LC is an employee of ReCor Medical. MA has received research grants from The French Ministry of Health, Quantum genomics and European H2020 program; has received grant support and non-financial support from ReCor Medical and Idorsia; and has received personal fees from CVRx. MDL has received personal fees from ReCor Medical, Medtronic, CVRx, Ablative Solutions, Vascular Dynamics, ROX Medical and Tarilan Laser Technologies and grants from Medtronic. All other authors declare no competing interests.
